Covid-19: Update

Lord Sharpe of Epsom Excerpts

Tuesday 20th April 2021 Lords Chamber

[Lord Sharpe of Epsom (Con)]

My Lords, one of the very few positives to come out of the pandemic is that the spotlight has shone on the superb life sciences sector in this country. For example, 47% of all global genomic sequencing is conducted in the UK. Could my noble friend the Minister elaborate on any future collaboration plans between the Government and the sector and how we intend to continue to grow our world-leading position in this space?

[Lord Bethell (Con)]

My noble friend is entirely right: life sciences is a huge national strength. It was a quiet industry that people did not speak of much; now it is centre stage. Post Brexit, the role of the MHRA, as one of the world’s leading regulators, is something of which we can be enormously proud as a country. It is also making a lot of businesses think that the UK should very much be the focus of their investment, going forward. BEIS and the DHSC are working together very closely, through the Office for Life Sciences, to ensure that the message is heard loud and clear, around the world, that Britain is the right place to invest.